Russian scientists present new cancer drug

The new drug activates inner powers to fight cancer and is created on the base of monoclonal antibodies.

A leading Russian biotech company has introduced a breakthrough cancer drug.

The company says early tests suggest the treatment is more effective in battling the disease than current analogues. The new drug activates inner powers to fight cancer and is created on the base of monoclonal antibodies.

Researchers say the key element of this therapy is that it can be used for treating not only one form of the oncology disease but also the whole group of such diseases with a common immunological power. The new drug has been prepared for clinical tests, with cancer patients from all over the world set to take part.

 


Press TV’s website can also be accessed at the following alternate addresses:

www.presstv.co.uk

SHARE THIS ARTICLE
Press TV News Roku